Yasoo Health to Develop First-of-Its Kind Multi-Vitamin for CF
| 1 min read

Yasoo Health to Develop First-of-Its Kind Multi-Vitamin for CF

Of all the vitamins currently on the market, none are geared to deal with the fat malabsorption problems faced by cystic fibrosis (CF) patients. That might change thanks to some novel research by Yasoo Health scientists.

On Feb. 7, Cystic Fibrosis Foundation Therapeutics (CFFT) awarded Yasoo Health, Inc. $936,375 to further develop its pilot multivitamin, which is formulated to deliver antioxidants and other essential nutrients to CF patients.

Earlier CFFT-supported studies, which used a liquid vitamin prototype, reported an increase in the blood level of antioxidants and other key nutrients in CF patients. These encouraging data prompted CFFT to offer Yasoo a larger, milestone-driven award, to fund the development of a proprietary multivitamin and antioxidant formulation.

Share this article
Topics
Research
Recent news
CF Foundation Reflects on Progress Toward Equity, Racial Justice, Diversity, and Inclusion
News | 4 min read
CF Foundation Invests Up to $3.5M in Gensaic for Novel Gene Delivery Method
News | 2 min read
CF Foundation Urges Vertex Pharmaceuticals to Reverse Consequential Decision on Copay Assistance
News | 3 min read
Stay up to date with The Foundation

Sign up for our newsletter to get all of the latest news from The Foundation right in your inbox.

Subscribe